ワシントンにおけるうつ病の臨床試験
ワシントン内の拠点で、うつ病に関する21件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07775300A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/25更新 · NCT06793397RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Seattle Neuropsychiatric Treatment Center, Seattle
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/14更新 · NCT07065240PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
- Seattle NTC, Seattle
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06713616A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/02更新 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/08/26更新 · NCT07300969Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/14更新 · NCT07226232A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/06更新 · NCT07412756E-Mindfulness Approaches for Living After Breast Cancer
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
被験者募集中第3相
18歳〜50歳 · 全性別 · 2026/08/04更新 · NCT06748222A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Core Clinical Research, Everett
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/08/03更新 · NCT06775379A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Core Clinical Research /ID# 226374, Everett
被験者募集中第3相
10歳〜17歳 · 全性別 · 2026/07/27更新 · NCT04777357Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT06966401CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
- Madigan Army Medical Center, Fort Lewis
被験者募集中
18歳以上 · 全性別 · 2026/07/13更新 · NCT05663034TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Seattle Children's Hospital, Seattle
被験者募集中観察研究
18 Months – 11 Years · 全性別 · 2026/07/06更新 · NCT07048574A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- Center For Anxiety and Depression, Mercer Island
- Seattle Neuropsychiatric Treatment Center, Seattle
被験者募集中
18歳以上 · 全性別 · 2026/06/15更新 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/05/11更新 · NCT06524830Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- Seattle Children's Hospital, Seattle
被験者募集中
12歳〜22歳 · 全性別 · 2025/10/30更新 · NCT06232304Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/29更新 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
被験者募集中第4相
18歳〜65歳 · 全性別 · 2025/01/23更新 · NCT06223880Lay-Delivered Behavioral Activation in Senior Centers
- Enumclaw Senior Center, Enumclaw
- Casa Latina, Seattle
- Centro de la Raza, Seattle
- 他1件
被験者募集中
60歳以上 · 全性別 · 2024/10/15更新 · NCT04621877ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。